Skip to content

Intramuscular Paracetamol Versus Intramuscular Tramadol as an Intrapartum Labour Analgesia: A Randomised Controlled Trial

Intramuscular Paracetamol Versus Intramuscular Tramadol as an Intrapartum Labour Analgesia: A Randomised Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202203615684194
Enrollment
140
Registered
2022-03-15
Start date
2019-05-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

intramuscular paracetamol group
intramuscular tramadol group

Sponsors

Ebere Ikenna
Lead Sponsor
Chidebe C Anikwe
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) booked pregnant women 2) spontaneous onset of labour 3) term singleton fetus, in cephalic presentation 4) no contraindication to vaginal delivery 5) consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Refusal to give consent 2. Patients with multiple gestation 3. Patients who presented at a gestational age below 37 weeks 4. Patients with history narcotics dependency 5. Patients with cardiopulmonary depression 6. Fetal distress 7. Intrauterine fetal death 8. Antepartum haemorrhage 9. History of recent chronic liver disease 10. Vaginal birth after Caeserean section 11. Breech presenting fetuses 12. History of renal disease 13. Known allergy to acetaminophen/tramadol 14. Any contraindication to vaginal delivery 15. Induced labour

Design outcomes

Primary

MeasureTime frame
The efficacy of paracetamol or tramadol in achieving labour analgesia using the visual analogue scale.

Secondary

MeasureTime frame
1. Total duration of the labour event. 2. Presence of adverse maternal or foetal effect 3. Need for additional analgesia 4. Maternal satisfaction

Countries

Nigeria

Contacts

Public ContactIkenna;Leonard Ebere;Ajah

senior registrar;consultant

ikenna_ebere@yahoo.com;leookpanku@yahoo.com+2348033972548;+2348033920789

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026